Last update 01 Nov 2024

Changchun First Test of Chinese Patent Medicine Co., Ltd.

Private Company|
2019|
Jilin Sheng, China

Overview

Tags

Respiratory Diseases
Infectious Diseases
Antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Antibody1
Top 5 TargetCount
influenza virus M11

Related

1
Drugs associated with Changchun First Test of Chinese Patent Medicine Co., Ltd.
TAT-HuScFv
Target
influenza virus M1
Mechanism
influenza virus M1 inhibitors
Active Org.
Chinese Academy of Agricultural SciencesChinese Academy of Agricultural Sciences [+2]
Originator Org.
Zhong Guo Nong Ye Ke Xue Yuan Chang Chun Shou Yi Yan Jiu Suo
Active Indication
influenza A subtype H5N1 infection
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Changchun First Test of Chinese Patent Medicine Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Changchun First Test of Chinese Patent Medicine Co., Ltd.
Login to view more data
100 Deals associated with Changchun First Test of Chinese Patent Medicine Co., Ltd.
Login to view more data
100 Translational Medicine associated with Changchun First Test of Chinese Patent Medicine Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
TAT-HuScFv
 ( influenza virus M1 )		influenza A subtype H5N1 infection
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free